“Do We Want Science to Reinvent Human Aging?”
By Bill McKibben and Gregory Stock,
Transcript of live debate
| 03. 27. 2003
Daniel Perry, Executive Director, Alliance for Aging Research:
Good afternoon, my name is Dan Perry and I’m the Executive
Director of the not-for-profit Alliance for Aging Research.
It gives me great pleasure to welcome you to the second debate
under the banner of SAGE Crossroads. This is a project that
will continue for the next three years, bringing to light the
crosscurrents in our political life that affect the science
of aging. We know that there is a great deal of research going
on in the United States and around the world trying to plum
the secrets of human aging, and as it increasingly becomes possible
to modify the trajectory of human aging there will certainly
be consequences, indeed controversies, that go to our economics,
our politics, our religion and our sense of ourselves as human
beings.
Today’s debate is one that really brings focus very sharply
on this question, as we will soon hear from our two esteemed
participants, Doctor Gregory Stock, who is the director of UCLA’s
Program on Medicine, Technology and Society, and a widely quoted
lecturer...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...
By Emily Mullin, Wired | 10.30.2025
In 2018, Chinese scientist He Jiankui shocked the world when he revealed that he had created the first gene-edited babies. Using Crispr, he tweaked the genes of three human embryos in an attempt to make them immune to HIV and...